Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 48

1.

HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance.

Carozzi FM, Del Mistro A, Cuschieri K, Frayle H, Sani C, Burroni E.

J Clin Virol. 2016 Mar;76 Suppl 1:S22-8. doi: 10.1016/j.jcv.2015.10.025. Epub 2015 Nov 10. Review.

PMID:
26669512
2.

Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?

Carozzi F, Tamburrino L, Bisanzi S, Marchiani S, Paglierani M, Di Lollo S, Crocetti E, Buzzoni C, Burroni E, Greco L, Baldi E, Sani C.

J Cancer Res Clin Oncol. 2016 Jan;142(1):201-12. doi: 10.1007/s00432-015-2015-1. Epub 2015 Jul 26.

PMID:
26210155
3.

Optimal timing of valve replacement in asymptomatic severe aortic stenosis.

Bilen E, Ipek G, Ayhan H, Nacar AB, Kasapkara HA, Sani C, Basbug S, Kurt M, Bozkurt E.

J Heart Valve Dis. 2014 Sep;23(5):524-33. Review.

PMID:
25799699
4.

Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.

Burroni E, Bonanni P, Sani C, Lastrucci V, Carozzi F; Hpv ScreeVacc Working Group, Iossa A, Andersson KL, Brandigi L, Di Pierro C, Confortini M, Levi M, Boccalini S, Indiani L, Sala A, Tanini T, Bechini A, Azzari C.

J Med Virol. 2015 Mar;87(3):508-15. doi: 10.1002/jmv.24085. Epub 2014 Nov 21.

PMID:
25418873
5.

Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study.

Gillio-Tos A, De Marco L, Carozzi FM, Del Mistro A, Girlando S, Burroni E, Frayle-Salamanca H, Giorgi Rossi P, Pierotti P, Ronco G; New Technologies for Cervical Cancer Screening Working Group.

J Clin Microbiol. 2013 Sep;51(9):2901-7. doi: 10.1128/JCM.01047-13. Epub 2013 Jun 26.

6.

Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women.

Levi M, Bonanni P, Burroni E, Bechini A, Boccalini S, Sani C, Bonaiuti R, Indiani L, Azzari C, Lippi F, Carozzi F; HPV Screevacc Working Group.

Hum Vaccin Immunother. 2013 Jul;9(7):1407-12. doi: 10.4161/hv.24337. Epub 2013 Apr 9.

PMID:
23571176
7.

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

Carozzi F, Gillio-Tos A, Confortini M, Del Mistro A, Sani C, De Marco L, Girlando S, Rosso S, Naldoni C, Dalla Palma P, Zorzi M, Giorgi-Rossi P, Segnan N, Cuzick J, Ronco G; NTCC working group.

Lancet Oncol. 2013 Feb;14(2):168-76. doi: 10.1016/S1470-2045(12)70529-6. Epub 2012 Dec 21.

PMID:
23261355
8.

Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.

Burroni E, Bisanzi S, Sani C, Puliti D, Carozzi F.

J Med Virol. 2013 Jan;85(1):83-90. doi: 10.1002/jmv.23417. Epub 2012 Nov 4.

PMID:
23124863
9.

HPV testing is an efficient management choice for women with inadequate liquid-based cytology in cervical cancer screening.

Giorgi Rossi P, Carozzi F, Collina G, Confortini M, Dalla Palma P, De Lillo M, Del Mistro A, Ghiringhello B, Gillio-Tos A, Maioli P, Pellegrini A, Schiboni ML, Segnan N, Zaffina LM, Zorzi M, Ronco G; NTCC Working Group.

Am J Clin Pathol. 2012 Jul;138(1):65-71. doi: 10.1309/AJCP6J2OEFOYTRFD.

10.

[Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].

Giorgi Rossi P, Chini F, Borgia P, Guasticchi G, Carozzi FM, Confortini M, Angeloni C, Buzzoni C, Buonaguro FM; Gruppo di lavoro HPV Prevalenza.

Epidemiol Prev. 2012 Mar-Apr;36(2):108-19. Review. Italian.

PMID:
22706361
11.

Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.

Carozzi FM, Burroni E, Bisanzi S, Puliti D, Confortini M, Giorgi Rossi P, Sani C, Scalisi A, Chini F.

J Clin Microbiol. 2011 Apr;49(4):1446-51. doi: 10.1128/JCM.02311-10. Epub 2011 Feb 16.

12.

The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600).

Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, Di Pierro C, Grazzini G, Angeloni C, Capparucci P, Pellegrini A, Schiboni ML, Sperati A, Confortini M, Bellanova C, D'Addetta A, Mania E, Visioli CB, Sereno E, Carozzi F; Self-Sampling Study Working Group.

Br J Cancer. 2011 Jan 18;104(2):248-54. doi: 10.1038/sj.bjc.6606040. Epub 2010 Dec 21.

13.

Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.

Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, Scalisi A, Macis R, Chini F, Buonaguro FM, Giorgi Rossi P; HPV Prevalence Italian Working Group.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2389-400. doi: 10.1158/1055-9965.EPI-10-0131.

14.

Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.

Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E, Costantini AS, Gorini G.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):52-8. doi: 10.1016/j.ijrobp.2010.04.023. Epub 2010 Aug 12.

PMID:
20708344
15.

Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment.

Confortini M, Carozzi F, Zappa M, Ventura L, Iossa A, Cariaggi P, Brandigi L, Franchini M, Mirri F, Viacava P, Scarfantoni A, Bazzanti D, Sani C.

BMC Infect Dis. 2010 Jun 7;10:157. doi: 10.1186/1471-2334-10-157.

16.

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.

Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J; New Technologies for Cervical Cancer screening (NTCC) Working Group.

Lancet Oncol. 2010 Mar;11(3):249-57. doi: 10.1016/S1470-2045(09)70360-2. Epub 2010 Jan 18.

PMID:
20089449
17.

Rachipagus: a report of two cases - thoracic and lumbar.

Sanoussi S, Rachid S, Sani CM, Mahamane B, Addo G.

J Surg Tech Case Rep. 2010 Jan;2(1):27-9. doi: 10.4103/2006-8808.63720.

18.

Laparoscopic treatment of traumatic rupture of hydatid hepatic cyst--is it feasible?: A case report.

Feleppa C, D'Ambra L, Berti S, Magistrelli P, Sani C, Falco E.

Surg Laparosc Endosc Percutan Tech. 2009 Aug;19(4):e140-2. doi: 10.1097/SLE.0b013e3181a6f221.

PMID:
19692866
19.

Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis.

Carozzi FM, Bisanzi S, Falini P, Sani C, Venturini G, Lopes Pegna A, Bianchi R, Ronchi C, Picozzi G, Mascalchi M, Carrozzi L, Baliva F, Pistelli F, Tavanti L, Falaschi F, Grazzini M, Innocenti F, Paci E; ITALUNG Study Research group.

Lung Cancer. 2010 May;68(2):216-21. doi: 10.1016/j.lungcan.2009.06.015. Epub 2009 Jul 30.

PMID:
19646775
20.

Laparoscopic cholecystectomy in sickle cell patients in Niger.

Rachid S, Didier LJ, Badé MA, Sani CM, Habibou A.

Pan Afr Med J. 2009 Dec 6;3:19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk